Antimalarials may influence the risk of malignancy in systemic lupus erythematosus
AUTOR(ES)
Ruiz‐Irastorza, G
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1954667Documentos Relacionados
- Increased risk of cancer in patients with systemic lupus erythematosus.
- Systemic lupus erythematosus patient guide: influence on knowledge of the disease.
- Risk factors for ovarian failure in patients with systemic lupus erythematosus
- Comment on “Nutritional aspects and cardiovascular risk in systemic lupus erythematosus”
- THE HEART IN SYSTEMIC LUPUS ERYTHEMATOSUS